• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Gilead Sciences

Gilead Sciences

Gilead Sciences Inc GILD

Last Price$79.12Day Change (%)1.62%
Open Price$78.06Day Change ($)1.26
Day Range78.05–79.6352-Week Range76.67–111.11

As of Fri 9/30/2016 5:15:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Gilead Sciences Halts Test of Bowel Disease Treatment

    Gilead Sciences Halts Test of Bowel Disease Treatment

  2. UPDATE: Allergan is paying a stunning 500% premium to buy a clinical-stage biotech

    UPDATE: Allergan is paying a stunning 500% premium to buy a clinical-stage biotech

  3. UPDATE: At $300,000 a year, Sarepta's new drug is considered a steal

    UPDATE: At $300,000 a year, Sarepta's new drug is considered a steal

  4. News Highlights: Top Equities Stories of the Day

    News Highlights: Top Equities Stories of the Day

  5. Polycythemia Vera Pipeline Report 2016 - Review of 12 Companies & 15 Molecules - Research and Markets

    Polycythemia Vera Pipeline Report 2016 - Review of 12 Companies & 15 Molecules - Research and Markets

  6. Scientists Honored for Hep C Research

    Scientists Honored for Hep C Research

  7. AHF: New UCLA Study Shows Gay Men on PrEP Are 45 Times More Likely to Contract Syphilis; 25 Times More Likely To Be Infected With Gonorrhea

    AHF: New UCLA Study Shows Gay Men on PrEP Are 45 Times More Likely to Contract Syphilis; 25 Times More Likely To Be Infected With Gonorrhea

  8. Gilead Sciences Carving Out a Wider Moat

    StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.

  9. Quality at a Low Cost

    This ETF is a bargain for investors who want exposure to profitable companies with durable competitive advantages.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.